Long-term treatment with Enjaymo (sutimlimab-jome) in people with cold agglutinin disease (CAD) results in rapid and sustained reductions…
Articles by Marisa Wexler, MS
An experimental treatment called HMBD-011, designed to target self-reactive antibodies and the immune B-cells that produce them, showed efficacy in…
A Phase 1 trial testing Annexon Biosciences’ oral treatment candidate ANX1502 — for complement-mediated autoimmune disorders such as…
Note: This story was updated Jan. 30, 2023, to correct that the CARDINAL trial did not include a placebo group.
Special considerations should be taken when preparing a blood transfusion for someone with cold agglutinin disease (CAD), a recent…
People with cold agglutinin disease (CAD) reported clinically significant improvements in health-related quality of life after treatment with…
Even with treatment, many people with cold agglutinin disease (CAD) continue to experience moderate or severe anemia and hemolysis…
Global Genes and RARE-X, two nonprofit organizations dedicated to improving the lives of people with rare diseases like cold…
Although extremely rare, there have been cases of cold agglutinin disease (CAD) and related conditions following vaccination against COVID-19,…
VV-ECMO, a technique used to deliver oxygen to the body when the lungs are not working properly, can be used…